We are live on ! Find out more
MIP

Mondrian Investment Partners Portfolio holdings

AUM $6.69B
This Fund
S&P 500
This Quarter Est. Return
-10.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.72B
AUM Growth
-$1.18B
Cap. Flow
-$581M
Cap. Flow %
-12.32%
Top 10 Hldgs %
46.13%
Holding
142
New
45
Increased
33
Reduced
28
Closed
–

Top Buys

Rank Stock Value
1
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$58M
2
JNJ icon
Johnson & Johnson
JNJ
+$58M
3
DUK icon
Duke Energy
DUK
+$50.7M
4
TXN icon
Texas Instruments
TXN
+$30.1M
5
PG icon
Procter & Gamble
PG
+$20.7M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$331M
2
AVY icon
Avery Dennison
AVY
+$130M
3
BAX icon
Baxter International
BAX
+$122M
4
INGR icon
Ingredion
INGR
+$84.5M
5
ENIA
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 16.48%
2 Financials 14.72%
3 Healthcare 13.54%
4 Utilities 11.42%
5 Communication Services 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YUM icon
1
Yum! Brands
YUM
$40.7B
$330M 7%
5,742,709
-200,596
-3% -$12.1M
TEVA icon
2
Teva Pharmaceuticals
TEVA
$36.2B
$304M 6.44%
5,384,720
-5,097,549
-49% -$331M
PHI icon
3
PLDT
PHI
$4.26B
$255M 5.4%
5,522,448
+14,900
+0.3% +$846K
MR
4
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$236M 5%
10,788,200
-264,300
-2% -$6.75M
BAP icon
5
Credicorp
BAP
$31.1B
$198M 4.19%
1,857,993
-59,456
-3% -$7.19M
INFY icon
6
Infosys
INFY
$47.4B
$189M 4.02%
19,848,896
-2,720,200
-12% -$23.3M
CAE icon
7
CAE Inc. Common Shares
CAE
$8.3B
$184M 3.89%
12,985,009
-103,372
-0.8% -$1.14M
BSMX
8
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$173M 3.67%
23,577,007
-508,100
-2% -$4.22M
ENIA
9
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$161M 3.42%
23,664,627
-5,143,181
-18% -$39.3M
TSM icon
10
TSMC
TSM
$2.07T
$146M 3.1%
7,051,967
+807,489
+13% +$17M
BCE icon
11
BCE
BCE
$19.8B
$144M 3.05%
2,632,409
-26,332
-1% -$1.08M
MSFT icon
12
Microsoft
MSFT
$2.89T
$123M 2.61%
2,779,726
+427,625
+18% +$19.2M
PFE icon
13
Pfizer
PFE
$141B
$110M 2.32%
3,674,880
-300,364
-8% -$9.63M
VALE.P
14
DELISTED
Vale S A
VALE.P
$107M 2.26%
31,819,914
-4,346,600
-12% -$18M
IBM icon
15
IBM
IBM
$204B
$95.9M 2.03%
692,231
+19,811
+3% +$2.93M
PG icon
16
Procter & Gamble
PG
$346B
$92.3M 1.96%
1,282,575
+276,209
+27% +$20.7M
RBA icon
17
RB Global
RBA
$21.7B
$85M 1.8%
2,464,363
+263,925
+12% +$7.22M
TSN icon
18
Tyson Foods
TSN
$21.4B
$78.4M 1.66%
1,819,957
-63,171
-3% -$2.69M
ABEV icon
19
Ambev
ABEV
$47.4B
$75.7M 1.61%
15,457,900
+234,300
+2% +$1.27M
UNH icon
20
UnitedHealth
UNH
$379B
$66.6M 1.41%
573,674
-172,708
-23% -$20.7M
WMT icon
21
Walmart Inc
WMT
$889B
$60.5M 1.28%
2,798,130
+244,959
+10% +$5.62M
PAC icon
22
Grupo Aeroportuario del Pacifico
PAC
$12.9B
$59.1M 1.25%
681,051
-429,100
-39% -$34.5M
JNJ icon
23
Johnson & Johnson
JNJ
$641B
$56M 1.19%
599,741
+599,241
+119,848% +$58M
ORCL icon
24
Oracle
ORCL
$345B
$55.5M 1.18%
1,537,097
+134,053
+10% +$5.15M
NTRS icon
25
Northern Trust
NTRS
$22.4B
$54.8M 1.16%
803,829
-26,792
-3% -$1.97M
1
2 3 4 5

Similar funds

AACR
ACR Alpine Capital Research St. Louis, Missouri $6.7B AUM 33.44% 1-Year Est. Return
MSE
MUFG Securities EMEA London, United Kingdom $6.7B AUM 32.3% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
TB
Thoma Bravo Chicago, Illinois $6.65B AUM 29.42% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return
BHM
Briar Hall Management Nashville, Tennessee $6.72B AUM 4.95% 1-Year Est. Return
SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Mondrian Investment Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Mondrian Investment Partners held 142 positions worth $4.72B, down 20% from $5.9B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Mondrian Investment Partners withdrew a net $581M in Q3 2015, reducing 28 holdings. Its largest reduction was Teva Pharmaceuticals, cutting an estimated $331M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Mondrian Investment Partners opened a new position in BAXALTA INC COM STK (DE) worth $52.9M.

  • Mondrian Investment Partners's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 1,680,166 shares worth $52.9M.
  • Mondrian Investment Partners added most to Johnson & Johnson in Q3 2015, an estimated $58M increase.
  • Mondrian Investment Partners's biggest Q3 2015 reduction was Teva Pharmaceuticals, cutting an estimated $331M.
  • Mondrian Investment Partners's ten largest holdings make up 46% of its $4.72B portfolio in Q3 2015.
  • Mondrian Investment Partners opened 45 new positions and closed 0 in Q3 2015.
  • Mondrian Investment Partners's portfolio value fell 20% quarter-over-quarter to $4.72B.

Based on Mondrian Investment Partners's 13F filing for Q3 2015, filed 20 Oct 2015.